Healthcare Roundtable: Under the Microscope

Published November 25, 2013

Healthcare Roundtable: Under the microscope
This dual messaging we are all responsible for is crucial because there will be a lot of real-time discussion taking place at physicians' offices and we need to make sure consumers come in with the right questions. Wendy Johnson-Askew … We understand … Read more on PRWeek

Actelion Announces U.S. Commercial Availability of OPSUMIT® (macitentan) as …
SOUTH SAN FRANCISCO–(BUSINESS WIRE)–Actelion (SIX: ATLN) today announced the commercial availability of OPSUMIT® (macitentan) 10mg, an oral, dual endothelin receptor antagonist (ERA) approved for the treatment of pulmonary arterial hypertension … Read more on EON: Enhanced Online News (press release)